Oct. 30, 2002 (New Orleans) — Findings from two new randomized trials suggest that the anti-tumor necrosis factor (TNF)-alpha agents infliximab (Remicade) and etanercept (Embrel) are effective ...

The cost per ACR50/70 response ratio favored the labeled dose of etanercept compared with both the low (3 mg/kg every 8 weeks) and high (10 mg/kg every 4 weeks) maintenance doses of infliximab.

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has been added to ...

In contrast to etanercept, infliximab binds in vitro to lymphocytes and induces apoptosis in activated cells. 34 The limited data available on the use of infliximab in Wegener's granulomatosis ...

Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com ...

This finding has been reported with both infliximab and etanercept and in patients with Crohn's disease as well as in those with rheumatoid arthritis. 5,7,9,30 The mechanisms of this phenomenon ...

DUBLIN, Feb. 5, 2021 /PRNewswire/ -- The "Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets ...

The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE) to produce guidance on using etanercept, infliximab and adalimumab for the treatment of psoriatic ...

“Cox proportional hazards regression was used to compare rates of serious infection for each exposure (acitretin, adalimumab, apremilast, etanercept, infliximab, and ustekinumab) with the ...

In one abstract, researchers sought to evaluate the impact of the Biosimilars Initiative in British Columbia, Canada, on uptake and spending for infliximab, etanercept, and adalimumab biosimilars.